 Regeneron Pharmaceuticals, Inc. NASDAQ:REGN Q2 2022 Earnings Conference Call August 3, 2022 8:30 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations Leonard Schleifer - President, Chief Executive Officer George Yancopoulos - President, Chief Scientific Officer Marion McCourt - Executive Vice President, Head of Commercial Robert Landry - Executive Vice President, Chief Financial Officer Conference Call Participants Mohit Bansal - Wells Fargo Evan Seigerman - BMO Capital Markets Tyler Van Buren - Cowen Salveen Richter - Goldman Sachs Matthew Harrison - Morgan Stanley Tim Anderson - Wolfe Research Chris Raymond - Piper Sandler Carter Gould - Barclays Capital Operator Welcome to the Regeneron Pharmaceuticals Second Quarter 2022 Earnings Conference Call. My name is Bella and I will be your operator for todays call. 